Clin2
NCT05948579Possibly a fitNot yet recruiting

Vilazodone for PTSD in a DoD research program

Post Traumatic Stress Disorder

Part of Mental health clinical trials.

This trial tests vilazodone (a prescription medicine) for post-traumatic stress disorder (PTSD). It aims to see whether this treatment improves PTSD symptoms for people who meet the study’s main protocol requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must meet the main study’s entry rules in the master protocol (NCT05422612).
  • You should not have already taken vilazodone 20–40 mg daily for at least 4 weeks for PTSD.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05441280Recruiting· Phase 2
Pimavanserin to improve sleep in veterans with PTSD

This Phase 2 trial studies pimavanserin, a medicine meant to improve insomnia, in veterans who also have PTSD. It may help reduce problems with falling asleep, staying asleep, or waking too early that affect daytime functioning.

Houston, Texas
NCT07664631Not yet recruiting· Phase 1
Testing stimulant medications for PTSD

This study tests whether stimulant medications can help treat PTSD symptoms. Researchers want to see if these medications are safe and effective for people with PTSD.

Chicago, Illinois
NCT07704762Not yet recruiting· Phase 2
MDMA-assisted therapy for PTSD in military members

This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.

NCT07079761Recruiting· Phase 2
PTSD treatment study with a hormone-like drug

This trial tests if a single infusion of allopregnanolone (a natural brain chemical) can help people with PTSD reduce fear responses and improve memory processing. It may offer a new way to treat PTSD by targeting how the brain stores traumatic memories.

Boston, Massachusetts
NCT05790239Recruiting· Phase 2
MDMA therapy sessions for veterans with PTSD

This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.

Los Angeles, California
NCT07456696Recruiting· Phase 3
TSND-201 for PTSD treatment study

This trial tests if an investigational drug called TSND-201 can help treat PTSD. It is for people who have tried at least one other PTSD treatment before.

Tucson, Arizona

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.